Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Sensor, Glucose, Invasive, Component of automated insulin delivery system

Número de PMA: P250012 · 2026-07-21

SolicitanteMedtronic Minimed, Inc.
Fecha de decisión2026-07-21
Número PMAP250012
Código de productoSFI
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorCH

Resumen del dispositivo

Sensor, Glucose, Invasive, Component of automated insulin delivery system is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Minimed, Inc.. It received FDA 510(k) clearance on 2026-07-21. The device is classified under product code SFI. It was reviewed by the CH advisory panel.

Preguntas frecuentes

What is the Sensor, Glucose, Invasive, Component of automated insulin delivery system?

Sensor, Glucose, Invasive, Component of automated insulin delivery system is a medical device that received FDA 510(k) clearance on 2026-07-21. The listed applicant is Medtronic Minimed, Inc..

When did Sensor, Glucose, Invasive, Component of automated insulin delivery system receive FDA 510(k) clearance?

The clearance date for Sensor, Glucose, Invasive, Component of automated insulin delivery system can be found in the official FDA records.

Who is the listed applicant for Sensor, Glucose, Invasive, Component of automated insulin delivery system?

The FDA 510(k) record lists Medtronic Minimed, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Sensor, Glucose, Invasive, Component of automated insulin delivery system?

The FDA product code for Sensor, Glucose, Invasive, Component of automated insulin delivery system is SFI.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑